Efficacy and safety of semaglutide 2.4 mg in the Japanese subgroup of the ESSENCE study

Conference Reports for NATAP

EASL - European Association
for the Study of the Liver
Barcelona, Spain
May 27-30, 2026


Efficacy and safety of semaglutide 2.4 mg in the Japanese subgroup of the ESSENCE study

	EASL 2026 May 26-30 Barcelona Atsushi Nakajima1,2, Takeshi Okanoue3, Yoichi Hiasa4, Hirokazu Takahashi5, Adel Belloum6*, Nobuyoshi Kosaka7, Tomoyuki Nishida7, Arun J. Sanyal8